Alpha 2.0
Login Register
» Articles » PMID: 3065114

Antibodies to a Mr-64,000 Islet Cell Protein in Swedish Children with Newly Diagnosed Type 1 (insulin-dependent) Diabetes

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1988 Aug 1
PMID 3065114
Citations 29
Authors
M Christie
M Landin-Olsson
G Sundkvist
G Dahlquist
A Lernmark
S Baekkeskov
Affiliations
Soon will be listed here.
Abstract

Sera from 40 Swedish children diagnosed as having Type 1 (insulin-dependent) diabetes mellitus during a one year period along with 40 age and geographically matched control subjects were tested for antibodies to a Mr-64,000 islet protein by immunoprecipitation of 35S-methionine-labelled rat islet amphiphilic proteins. Of the 40 diabetic patients, 29 (73%) were found to be positive whereas all 40 control subjects were negative. Samples were also tested for titres of islet cell cytoplasmic antibodies by indirect immunofluorescence on frozen sections of human pancreas. In the diabetic group, 30 of the 40 patients (75%) were positive for islet cell cytoplasmic antibodies compared with 2 of the 40 control subjects (5%). A comparison of levels of antibodies to the Mr-64,000 protein with islet cell cytoplasmic antibodies revealed a weak (rs = 0.46), but significant (p less than 0.01) correlation between the two tests. There was no effect of age or sex on levels of antibodies to the Mr-64,000 protein. These results in population-based diabetic children and control subjects demonstrate a high frequency of antibodies to the Mr-64,000 protein at the time of clinical onset.

Citing Articles

Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden.

Torn C, Vaziri-Sani F, Ramelius A, Elding Larsson H, Ivarsson S, Amoroso M Acta Diabetol. 2022; 59(6):773-781.

PMID: 35220476 PMC: 9085662. DOI: 10.1007/s00592-022-01856-5.

Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus.

Trabucchi A, Bombicino S, Targovnik A, Marfia J, Sabljic A, Faccinetti N Sci Rep. 2019; 9(1):824.

PMID: 30696851 PMC: 6351654. DOI: 10.1038/s41598-018-35744-2.

A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.

Sharma C, Pandey R, Kumawat B, Khandelwal D, Gandhi P Ann Indian Acad Neurol. 2016; 19(1):146-9.

PMID: 27011652 PMC: 4782537. DOI: 10.4103/0972-2327.165462.

Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway.

Sorgjerd E, Skorpen F, Kvaloy K, Midthjell K, Grill V Diabetologia. 2012; 55(5):1310-8.

PMID: 22297581 DOI: 10.1007/s00125-012-2463-y.

Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Gebe J, Unrath K, Falk B, Ito K, Wen L, Daniels T Clin Immunol. 2006; 121(3):294-304.

PMID: 16979383 PMC: 1850983. DOI: 10.1016/j.clim.2006.08.002.

References
1.
Bottazzo G, Florin-Christensen A, Doniach D . Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974; 2(7892):1279-83. DOI: 10.1016/s0140-6736(74)90140-8. View
2.
Nayak R, Omar M, Rabizadeh A, Srikanta S, Eisenbarth G . "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate. Diabetes. 1985; 34(6):617-9. DOI: 10.2337/diab.34.6.617. View
3.
Colman P, Campbell I, Kay T, Harrison L . 64,000-Mr autoantigen in type I diabetes. Evidence against its surface location on human islets. Diabetes. 1987; 36(12):1432-40. DOI: 10.2337/diab.36.12.1432. View
4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View
5.
Bonifacio E, Lernmark A, Dawkins R . Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods. 1988; 106(1):83-8. DOI: 10.1016/0022-1759(88)90274-8. View